| Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials Y Wang, Q Luo, Y Li, S Deng, S Wei, X Li PloS one 9 (1), e84484, 2014 | 179 | 2014 |
| Can comprehensive chromosome screening technology improve IVF/ICSI outcomes? A meta-analysis M Chen, S Wei, J Hu, S Quan PloS one 10 (10), e0140779, 2015 | 155 | 2015 |
| Feasibility and safety of robot-assisted thoracic surgery for lung lobectomy in patients with non-small cell lung cancer: a systematic review and meta-analysis S Wei, M Chen, N Chen, L Liu World journal of surgical oncology 15, 1-9, 2017 | 117 | 2017 |
| Does time-lapse imaging have favorable results for embryo incubation and selection compared with conventional methods in clinical in vitro fertilization? A meta-analysis and … M Chen, S Wei, J Hu, J Yuan, F Liu PloS one 12 (6), e0178720, 2017 | 92 | 2017 |
| Effect of vein-first vs artery-first surgical technique on circulating tumor cells and survival in patients with non–small cell lung cancer: a randomized clinical trial and … S Wei, C Guo, J He, Q Tan, J Mei, Z Yang, C Liu, Q Pu, L Ma, Y Yuan, ... JAMA surgery 154 (7), e190972-e190972, 2019 | 90 | 2019 |
| Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review Y Tan, S Wei, W Zhang, J Yang, J Yang, L Yan Cancer Management and Research, 705-713, 2019 | 53 | 2019 |
| The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis P Tan, S Wei, L Yang, Z Tang, D Cao, L Liu, J Lei, Y Fan, L Gao, Q Wei Scientific reports 6 (1), 29106, 2016 | 42 | 2016 |
| Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review P Tan, C Zhang, SY Wei, Z Tang, L Gao, L Yang, Q Wei Asian journal of andrology 19 (6), 666-671, 2017 | 41 | 2017 |
| LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies P Tan, S Wei, Z Tang, L Gao, C Zhang, P Nie, L Yang, Q Wei Scientific Reports 6 (1), 24521, 2016 | 30 | 2016 |
| The effect of oral phosphodiesterase-5 inhibitors on sperm parameters: a meta-analysis and systematic review P Tan, L Liu, S Wei, Z Tang, L Yang, Q Wei Urology 105, 54-61, 2017 | 29 | 2017 |
| Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma K Du, S Wei, Z Wei, DT Frederick, B Miao, T Moll, T Tian, E Sugarman, ... Nature communications 12 (1), 6023, 2021 | 27 | 2021 |
| Targeting HSP90 as a novel therapy for cancer: mechanistic insights and translational relevance J Zhang, H Li, Y Liu, K Zhao, S Wei, ET Sugarman, L Liu, G Zhang Cells 11 (18), 2778, 2022 | 26 | 2022 |
| Survival benefit of left lower paratracheal (4L) lymph node dissection for patients with left-sided non-small cell lung cancer: once neglected but of great importance K Zhao, S Wei, J Mei, C Guo, Y Hai, N Chen, L Liu Annals of Surgical Oncology 26, 2044-2052, 2019 | 26 | 2019 |
| Challenges and a response strategy for the development of nursing in China: a descriptive and quantitative analysis Y Wang, S Wei, Y Li, S Deng, Q Luo, Y Li Journal of Evidence‐Based Medicine 6 (1), 21-33, 2013 | 26 | 2013 |
| ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer Z Liu, K Zhao, S Wei, C Liu, J Zhou, Q Gou, X Wu, Z Yang, Y Yang, ... Oncoimmunology 9 (1), 1758003, 2020 | 21 | 2020 |
| Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer Y Wang, Q Luo, Y Li, H Wang, S Deng, S Wei, X Li PLoS One 9 (8), e103939, 2014 | 20 | 2014 |
| A modified nucleoside 6-Thio-2′-deoxyguanosine exhibits antitumor activity in gliomas S Yu, S Wei, M Savani, X Lin, K Du, I Mender, S Siteni, T Vasilopoulos, ... Clinical Cancer Research 27 (24), 6800-6814, 2021 | 15 | 2021 |
| Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers Z Yang, Y Deng, J Cheng, S Wei, H Luo, L Liu Frontiers in Oncology 11, 695006, 2021 | 13 | 2021 |
| Antitumor activity of a mitochondrial-targeted HSP90 inhibitor in gliomas S Wei, D Yin, S Yu, X Lin, MR Savani, K Du, Y Ku, D Wu, S Li, H Liu, ... Clinical Cancer Research 28 (10), 2180-2195, 2022 | 12 | 2022 |
| Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma X Leng, S Wei, J Mei, S Deng, Z Yang, Z Liu, C Guo, Y Deng, L Xia, ... Translational Lung Cancer Research 10 (2), 965, 2021 | 11 | 2021 |
